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Abstract. Although it is generally believed that phos- 
phorylation of the regulatory light chain of myosin is 
required before smooth muscle can develop force, it is 
not known if the overall degree of phosphorylation can 
also modulate the rate at which cross-bridges cycle. To 
address this question, an in vitro motility assay was 
used to observe the motion of single actin filaments 
interacting  with smooth muscle myosin copolymers 
composed of varying ratios of phosphorylated and 
unphosphorylated myosin.  The results suggest that un- 
phosphorylated myosin acts as a load to slow down 
the rate at which actin is moved by the faster cycling 
phosphorylated cross-bridges.  Myosin that was chemi- 
cally modified to generate a noncycling analogue of 
the "weakly" bound conformation was similarly able to 
slow down phosphorylated myosin. The observed 
modulation of actin velocity as a function of 
copolymer composition can be accounted for by a 
model based on mechanical  interactions between 
cross-bridges. 
S 
MOOTH muscle generates comparable or greater force 
per  cross-sectional  area  than  skeletal  muscle while 
consuming 300 times less energy (i.e., ATP) (Paul et 
al.,  1976; Siegman  et al.,  1980).  The molecular basis for 
this economy of force production may depend on how the 
most basic contractile structure,  the myosin cross-bridge, in- 
teracts with neighboring actin filaments (Murphy,  1980; Fay 
et ai., 198I; Hellstrand and Paul, 1982). Although the cross- 
bridge cycle in smooth and skeletal  muscle is qualitatively 
similar, these muscles differ in their mode of regulation which 
may account for the unique contractile capabilities  of the 
smooth muscle cell. 
Phosphorylation of the 20-kD myosin light  chain is re- 
quired to initiate  contraction and rapid cross-bridge cycling 
in smooth muscles (for review see Kamm and Stull,  1985). 
In addition to acting  simply as an "on-off" switch,  Murphy 
and co-workers (Dillon et al., 1981) proposed that the degree 
of light chain phosphorylation may also modulate the rate at 
which cross-bridges cycle. This modulatory role was based 
on the observation that both light chain phosphorylation and 
shortening  velocity peaked early in a contraction and then 
fell during the period of force maintenance (Dillon et al., 
1981). To account for the temporal correlation between these 
two parameters, Murphy and co-workers suggested that two 
mechanically distinct cross-bridge populations can interact: 
a population of rapidly cycling phosphorylated cross-bridges 
and a slower or noncycling  population of latchbridges  that 
are dephosphorylated by phosphatases (Dillon et ai., 1981). 
As  more  cross-bridges  are  dephosphorylated  during  the 
period of force maintenance,  they would impose a load on 
the faster cycling phosphorylated cross-bridges, thus reduc- 
ing the muscle's shortening  velocity. Alternatively,  although 
light chain phosphorylation and shortening  velocity are cor- 
related in time, a mechanism other than light  chain  phos- 
phorylation could modulate the cycling  rate of the entire 
cross-bridge population (Butler and Siegman,  1985). 
The  hypothesis  that  populations  of  cross-bridges  can 
mechanically  interact  to modulate shortening  velocity was 
tested  by an  in  vitro  motility  assay (Kron  and  Spudich, 
1986).  The rate at which actin  slides  over smooth muscle 
myosin  filaments  containing  varying  proportions  of un- 
phosphorylated and phosphorylated myosin was measured. 
The results suggest that unphosphorylated cross-bridges im- 
pose a significant load on normally cycling phosphorylated 
cross-bridges.  The  extent  of this  load  was  estimated  in- 
directly by studying actin filament motion on myosin copoly- 
mers containing  smooth and either unmodified or modified 
skeletal  muscle myosins.  Based on these observations,  a 
mechanistic model was developed that describes the modula- 
tion of the rate of actin movement by mechanical interactions 
between cross-bridges. 
Materials and Methods 
Contractile Protein Isolation and Preparation 
Unphosphorylated smooth muscle myosin  was  isolated  from turkey giz- 
zards (Sellers et al.,  1981). Myosin was completely thiophosphorylated 
upon addition of myosin light chain kinase, calmodulin, calcium, and ATP- 
"/-S (Trybus and Lowey, 1984), as determined by glyeerol/acrylamide  gels 
(Perrie  and  Perry,  1970).  Skeletal  muscle  myosin was  prepared  from 
chicken pectoralis (Margossian and Lowey, 1982).  The purified myosins 
were stored in monomeric form at -200C in a 50% glycerol  solution. 
Unregulated actin was purified from chicken pectoralis acetone powder 
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The Journal of Cell Biology, Volume 111, August 1990 453-463  453 Figure 1. (A) Experimental flow-through microchamber. A coverslip, coated with nitrocellulose, was placed on two small support pieces 
of coverslip with the coated surface facing the microscope slide. The edges of the chamber were sealed with grease (Apiezon M) (stippled 
area). (B) Electron micrograph of negatively stained phosphorylated smooth muscle myosin filaments on a nitrocellulose coated coverslip 
at 300/zg/ml. See text for details of filament preparation for electron microscopy. (C) Movement of a single fluorescently labeled actin 
filament in the presence of phosphorylated smooth muscle myosin. The image is a composite of four video snapshots taken 10 s apart. 
The average velocity of the filament in 1 mM MgATP assay buffer was 0.4 ~m/s. The arrow indicates the direction of motion. (D) Two 
individual actin filaments in the presence of unphosphorylated smooth muscle myosin. The image is a composite of three video snapshots 
spaced 10 s apart. There was no detectable motion since the first and last actin images were superimposable. 
by the methods of  Pardee and Spudich (1982) and stored in filamentous form 
at 4"C. Before a motility experiment, actin filaments were fluorescently la- 
beled overnight with TRITC phalloidin (Sigma Chemical Co., St. Louis, 
MO) (Kron and Spudich,  1986).  Protein concentrations were determined 
at X =  280 nm using the following extinction coefficients  (1 mg/ml): myosin, 
0.5; actin,  1.1. 
Preparation of  ChemicaUy Modified Myosin 
Skeletal muscle myosin was chemically modified to produce analogues of 
the "weak  ~ and "strong" actin binding conformations. Myosin that binds 
weakly to actin was prepared by reacting 2 mg/ml myosin with a  1.5-fold 
molar excess of N,N'-p-phenylenedimaleimide  (pPDM) l in 20 mM imida- 
zole, pH 7.5, 0.1 mM ADP, 0.2 mM MgCI2 for 75 rain on ice (Chalovich 
el al.,  1983).  The reaction was stopped by addition of 2  mM DTT.  Un- 
1.  Abbreviations  used  in  this paper:  NEM,  N-ethylmaleimide; pPDM, 
N ,N'-p-pbenylenedimaleimide. 
modified myosin was removed by pelleting the reaction mixture in the pres- 
ence of actin without MgATP. Approximately 60% of  the myosin remained 
in the supernatant and was assumed to be modified and in the weak binding 
state. Myosin that binds strongly to actin both in the presence and absence 
of MgATP was formed by extensive sulfhydryl modification with N-ethyl- 
maleimide (NEM). Myosin (2 mg/ml) in 20 mM imidazole (pH 7.5) was 
reacted with 0.5-1.0 mM NEM for 40 min at room temperature, and then 
stopped by addition of 25 mM DTT (Pemrick and Weber, 1976).  The per- 
centage of modified myosin ('~60% of the total) was determined from the 
amount of myosin that pelleted with actin in the presence of MgATP. 
Myosin Polymerization 
Filamentous myosin was formed by a single step dilution of monomeric my- 
osin in 0.3  M  KCI  standard buffer (25  mM imidazole, pH 7.4,  4  mM 
MgCI2,  1 mM EGTA, and 1 mM DTT) into 0.1 M KCI standard buffer. To 
form copolymers of either unphosphorylated and phosphorylated smooth 
muscle myosin or smooth and skeletal muscle myosins, the desired mono- 
mers were first mixed in 0.3 M KCI standard buffer and then diluted in 0.1 M 
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ments that were formed were ".,0.5  ~m tong (Fig.  1 B). 
Copolymers containing unphosphorylated smooth muscle myosin can be 
formed at low  ionic strength, but addition of MgATP depolymerizes  the fila- 
ment (Trybus and l.~wey,  1984).  Therefore, a recently developed monoclo- 
hal antibody specific for the smooth muscle myosin rod (LMM.I; Trybus 
and Henry, 1989; Trybus, 1989) was used to block filament depolymeriza- 
tion upon addition of nucleotide. After mixtures of monomers containing 
unphosphorylated  smooth  muscle  myosin  were  polymerized,  antibody 
LMM.1 was added in a threefold molar excess. These antibody stabilized 
filaments were then applied to the nitrocellulose-coated coverslip. 
Actin-activated ATPase Activity 
Inorganic phosphate was determined colorimetrically (Taussky  and Short, 
1953)  after the reaction was stopped with SDS as described by White 
(1982).  Rates were obtained from the average slope through three time 
points taken during the initial 30 % of the reaction. The activity of copoly- 
mers and homopolymers of phosphorylated and unphosphorylated smooth 
muscle myosin was determined in 20 mM imidazole, pH 7, 75 mM KC1, 
3 mM MgSO4,  1 mM EGTA, 37°C at Vr~x (20 #M actin, 5 ~tM gizzard 
tropomyosin) in the presence of antibody LMM.1. The actin-activated AT- 
Pase of smooth/skeletal muscle myosin copolymers was determined in 20 
mM imidazole, pH 7.5, 25 mM KCI, 4 mM MgCI2, I  mM EGTA, 370C 
with 20 #M actin in the presence of antibody LMM.I. 
Electron Microscopy 
The appearance and distribution of myosin filaments on the nitrocellulose- 
coated coverslip (Fig.  1 B) were determined by transmission electron mi- 
croscopy. Thin copper grids (300  mesh) were sandwiched between the 
nitrocellulose film and glass coverslip and then carbon coated (Kron and 
Spudich, 1986).  The coverslip, containing the copper grids, was then used 
to construct a flow cell. As in an experiment, myosin (250 #g/ml), in 0.1 M 
KCI standard buffer, was perfused into the flow cell. However, after 60 s, 
1% uranyl acetate was flushed through the flow cell at room temperature, 
negatively staining the filaments. The coverslip was then removed from the 
flow cell and allowed to dry on filter paper. The grids were removed and 
examined in a  Zeiss CA-10 electron microscope operated at 60 kV.  For 
higher magnification images of unphosphorylated smooth and skeletal mus- 
cle myosin copolymers (Fig. 4), copolymers (25-50 ~g/ml) were applied 
directly to a carbon-coated grid, negatively stained with 1% uranyl acetate, 
and then viewed in a Philips EM301 electron microscope operated at 80 kV. 
In Vitro Motility Assay 
The in vitro motility assay has been described in detail previously (Kron 
and Spudich, 1986;  Harada et al.,  1987; Toyoshima et al.,  1987; Kron et 
al., 1990).  In brief, a 30-~d flow-through chamber was created by support- 
ing a nitrocellulose-coated (1.0%) coverslip (18 mm  2, No. 1 glass) on a mi- 
croscope slide by two pieces of coverslip material (Fig.  1 A). By using a 
micropipetter, various test solutions were perfused through the chamber. To 
begin an experiment, 30 #1 of filamentous myosin (250 #g/ml) in 0.1 M KCI 
standard buffer were perfused into the chamber and the filaments allowed 
to adhere to the nitrocellulose for 60 s. The adherent myosin filaments were 
uniformly distributed in a random orientation on the coverslip (Fig.  1 B). 
Then 60/~1 of0A M KCI standard buffer containing BSA (0.5 mg/ml) were 
perfused through to wash out any unbound myosin and to coat any exposed 
nitrocellulose. Next, 30/~1 of fluorescently labeled filamentous actin (0.5 
ng/mi) in assay buffer (25 mM KCI standard buffer with 0.1 mg/ml glucose 
oxidase, 0.018 mg/ml catalase, and 2.3 mg/mi glucose) were added twice 
to the flow cell and the actin filaments allowed to bind to myosin for 30 s 
each time. Then 60 t~l of assay buffer were perfused through to wash out 
any free actin. Finally,  actin motion was observed after 90 #1 of  assay buffer 
containing 1 mM MgATP were perfused through the chamber (Fig.  1 C). 
All experiments were performed at room temperature unless noted. 
Detection and Analysis of  Actin Filament Motion 
Actin filament motion was observed using an inverted microscope (Zeiss 
IM) equipped for epifluorescence with a 100 W mercury lamp, and rhoda- 
mine filter set. Given the low level fluorescence, a high numerical aperture 
objective (63X Zeiss planapochromat, NA 1.4) and image intensified video 
camera (Dage 66 SIT) were used to record actin images on videotape (Sony 
SL-4FR70 VCR). An oxygen scavenger system was used (glucose oxidase 
and catalase) to reduce fluorescence photobleaching, allowing actin fila- 
ments to be visualized continuously for at least 3 min (Kishino and Yana- 
gida,  1988). 
To determine the velocity of actin movement, video images were digi- 
tized into a 480  x  512 pixel array by a video grabber card (Oculus 200; 
Coreco Inc., Ville St.-Laurent, Quebec, Canada) in a laboratory computer 
(IBM PC-XT). A p~Viously developed computer program (Work and War- 
shaw, 1988) was modified to take video snapshots at either 3-5 or 0.3 s be- 
tween images for smooth or skeletal muscle myosins, respectively (Fig.  1 
C). The investigator, using a mouse, located an actin filaments leading edge 
in successive snapshots, thus allowing the computer to calculate a mean ac- 
tin filament velocity.  Given the discreet nature of the digitized video image 
and the time between snapshots, the actin filament velocity resolution was 
0.30/~m/s for 0.3 s and 0.035/~m/s for 3.0 s snapshots, respectively. Only 
those filaments that moved continuously for at least 3 ~m were included in 
the data set. Under conditions where no filament motion was detected, a 
velocity equal to the lowest velocity resolution was assigned. The actin fila- 
ment velocities are presented as the mean and standard deviation of the 
means of at least 10 filaments for any experimental condition. 
Results 
Parameters  Affecting Actin Sliding Velocity 
Actin filament motion was highly dependent on the constitu- 
ents in the assay solution. In the absence of myosin, actin 
floated freely in solution and did not bind to the nitrocellu- 
lose-coated.coverslip. With myosin present on the coverslip, 
actin became rigidly bound. Upon addition of 1 mM MgATP, 
the actin moved in a directed and continuous fashion for dis- 
tances up to 20 ttm with average velocities of 0.2-0.4/zm/s 
with phosphorylated smooth muscle myosin (Fig.  1 C). The 
motion of actin was always unidirectional; filaments never 
stopped to reverse their motion. Within a given visual field, 
>80%  of the actin filaments moved. 
The velocity of actin sliding was independent of the con- 
centration  of filamentous  phosphorylated  smooth  muscle 
myosin between 62-1,000 #g/ml.  Below this concentration 
(i.e., low filament density),  the increased spacing between 
myosin filaments did not allow actin to undergo continuous 
motion over long (>3/zm) distances. The velocity of move- 
ment was also independent of actin filament length which 
varied between 0.5 and 4/~m (Fig. 2 A). Velocity was sensi- 
tive to MgATP concentration,  however, as might be expect- 
ed if actin filament motion reflects actomyosin interactions. 
At high MgATP concentrations  (>1  mM), phosphorylated 
smooth muscle myosin moved actin filaments at 0.303  ± 
0.030 ~m/s (n  =  10), an order of magnitude  slower than 
skeletal muscle myosin. The relationships between actin fila- 
ment velocity and MgATP concentration  were similar for 
both myosins when normalized to their respective maximum 
velocities (Fig. 2 B), with half maximal velocity occurring 
at 29/~M MgATP. 
Actin velocity increased with temperature: at 22°C, the av- 
erage velocity was 0.254 t~m/s compared with 0.546 txm/s  at 
32°C.  The apparent  Q~0 of 2.1  suggests that actin motion 
was caused by an active biochemical process and not simple 
diffusion, which would be expected to have a Qt0 <1.4. The 
similarity between the bell shaped pH dependence of actin 
filament velocity (Fig. 2 C) and the in vitro skeletal muscle 
actomyosin ATPase activity (Stone and Prevost, 1973) is ad- 
ditional evidence that actin movement is related to this enzy- 
matic process. Between pH 7.0 and 7.5, actin filament veloc- 
ity was maximal and thus all experiments were performed at 
pH 7.4. An ionic strength dependence of velocity was also 
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Figure 2. Parameters affecting  the rate of actin movement. (A) Actin filament velocity versus actin filament length. Velocities were obtained 
in the presence of fully phosphorylated smooth muscle myosin, 1 mM MgATP assay buffer at 22"C. The linear regression was described 
by: velocity = 0.173 #m/s +  (0.019/s) length; r  = 0.22. The slope of the regression was not significantly different than zero (P > 0.05). 
Therefore actin filament velocity was independent of actin filament length. (B) Actin filament velocity versus MgATP concentration. Actin 
filament velocities were obtained in the presence of either fully phosphorylated smooth muscle myosin (e) or skeletal muscle myosin (A). 
The velocities are normalized to their respective maximums (smooth = 0.3 #m/s; skeletal =  3.25 ttm/s). Data points are the means and 
standard deviations of the means for 10 filaments. The curve was fit by eye. (C) Actin filament velocity versus pH. Curve fit by eye. (D) 
Actin filament velocity versus KC1 concentration. 
observed: the average velocity increased from 0.145/~m/s at 
6 mM KC1 to 0.326 #m/s at 50 mM KCI (Fig. 2 D). Above 
60 mM KCI, experiments could not be done because actin 
binding was greatly diminished. 
Unphosphorylated Smooth Muscle Myosin Inhibits 
Actin Movement by Phosphorylated  Myosin 
The  rate  at  which  actin  moved over copolymers of un- 
phosphorylated and phosphorylated smooth muscle myosin 
was  determined to assess  whether the relative amount of 
phosphorylated myosin within a filament affected the veloc- 
ity of actin sliding. In all experiments, monoclonal antibody 
LMM.1  was  added  to  prevent  filaments  containing  un- 
phosphorylated myosin from depolymerizing upon addition 
of MgATP (Trybus and Henry, 1989; Trybus, 1989). Fully 
phosphorylated myosin filaments moved actin at 0.21  +  0.05 
/xm/s (n =  9) (Fig. 3 A) in the presence and absence of anti- 
body, suggesting that antibody LMM.1 does not alter acto- 
myosin interactions. Actin also bound to unphosphorylated 
myosin filaments, but no movement was detected (Fig. 1 D). 
The rigid appearance of the bound actin was similar to that ob- 
served when actin bound to myosin in the absence of MgATP, 
i.e., rigor. As the percentage of phosphorylated myosin in 
the copolymer decreased from 100 to 50%, actin filament 
velocity remained constant (Fig. 3 A). At 40% phosphorylat- 
ed myosin, however, the velocity fell precipitously with a 
half-maximal rate at 25 % phosphorylated myosin. This sig- 
moidal relationship was observed at ionic strengths varying 
between 25 and 60 mM KCI. If unphosphorylated myosin 
had no effect on phosphorylated myosin, then actin filament 
velocity would have been independent of the concentration 
of phosphorylated myosin. 
The modulation of actin filament velocity by light chain 
phosphorylation could be due to a change in the enzymatic 
activity of the myosin heads.  This phenomenon, however, 
was not observed by measuring the solution actin-activated 
ATPase  activity  of phosphorylated/unphosphorylated co- 
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Figure 3. (A) Actin filament velocity versus the percentage of either 
phosphorylated (lower axis) or unphosphorylated (upper axis) 
smooth muscle myosin in the copolymer. Velocities  are normalized 
to the maximums at a given KCI concentration (0.24 #m/s at 25 
mM, e; 0.32/zm/s at 40 raM, zx; 0.48 #m/s at 60 mM, ra). Curve 
was fit by eye through all the data. (B) Actomyosin  ATPase activity 
versus percentage  of  phosphorylated  smooth  muscle  myosin.  ATPase 
activity was obtained for copolymers (o) of unphosphorylated and 
phosphorylated myosin and for mixtures of unphosphorylated and 
phosphorylated smooth muscle myosin homopolymers (zx). 
polymers. The actin-activated activity was almost linearly 
proportional to the concentration of phosphorylated heads 
within a filament and quite similar to the ATPase activity of 
mixtures of homopolymers where no cooperative interactions 
would be expected (Fig. 3 B). These data suggest that in so- 
lution, myosin heads within a filament act independently and 
the ATPase activity of a phosphorylated head does not change 
depending on the neighboring molecules. The modulation of 
actin filament velocity seen in the motility assay may there- 
fore reflect a mechanical impedance that unphosphorylated 
cross-bridges impose on the faster cycling phosphorylated 
cross-bridges. 
Smooth Muscle Myosin Slows the Movement of  Actin 
by Skeletal Muscle Myosin 
If unphosphorylated cross-bridges impose an internal load 
on faster cycling cross-bridges, it may be possible to estimate 
this load indirectly by copolymerizing smooth and skeletal 
muscle myosins.  These  experiments  should  show  if two 
mechanically distinct cross-bridge populations can interact 
to modulate actin velocity. To insure that the interactions be- 
tween unphosphorylated smooth and skeletal muscle myosin 
cross-bridges occurred within the same filament, the copoly- 
mers were again stabilized by antibody LMM.1 to prevent de- 
polymerization  of  unphosphorylated smooth muscle myosin. 
The formation of copolymers between these two species 
was confirmed by electron microscopy. Negatively stained, 
antibody stabilized, smooth muscle myosin filaments (Fig. 
4 C) were distinctly different from the much longer skeletal 
muscle myosin homopolymers (Fig. 4 D). Notice the intense 
striped  appearance  of  smooth  muscle  myosin  filaments 
caused by binding of antibody LMM.1 specific for smooth 
muscle myosin (Fig. 4 C). When copolymers of smooth and 
skeletal muscle myosin were formed and then decorated with 
antibody, all filaments showed some "striping; suggesting 
that smooth muscle myosin was present in all polymers. In 
addition,  long antibody-free skeletal muscle myosin fila- 
ments were never observed in copolymer solutions (Fig. 4 
A) but were always seen in mixtures of smooth and skeletal 
muscle myosin homopolymers (Fig. 4 B). It was not readily 
apparent if the copolymers were of the bipolar or sidepolar 
morphology. 
Control experiments confirmed that antibody LMM.1 did 
not affect the ability of skeletal muscle myosin to move actin. 
When unphosphorylated smooth muscle myosin was copoly- 
merized with skeletal muscle myosin, however, the presence of 
only 12.5 % unphosphorylated smooth muscle myosin caused 
a significant reduction in velocity (Fig. 5 A). Note that much 
more unphosphorylated myosin was required to slow phos- 
phorylated smooth muscle myosin (Fig. 3 A). With further 
addition of  unphosphorylated myosin, the rate of actin move- 
ment continued to decrease and was completely inhibited 
once the proportion of unphosphorylated myosin reached 
50%. A similar relationship between actin filament velocity 
and skeletal muscle myosin content was observed for copoly- 
mers of  phosphorylated smooth and skeletal muscle myosins 
(Fig. 5 B). Once the percentage of phosphorylated myosin 
increased to 50 %, the velocity of actin filament movement 
was similar to that of  phosphorylated smooth muscle myosin 
homopolymers. 
The  actin-activated ATPase  activity of smooth/skeletal 
muscle myosin copolymers was measured to determine if 
modulation  of  actin  filament  velocity  merely  reflected 
changes in intrinsic ATPase activity. This was not the case 
because the actomyosin ATPase activity was approximately 
a weighted average of the activities of the two myosin spe- 
cies.  Smooth and skeletal muscle cross-bridges therefore 
hydrolyze MgATP independently of one another within the 
copolymer. 
Movement of  Actin over Copolymers Containing 
Analogues of Weak and Strong Actin Binding States 
Skeletal muscle myosin can be chemically modified to pro- 
duce cross-bridge states that no longer hydrolyze  MgATP but 
bind weakly (pPDM-myosin) or strongly (NEM-myosin) to 
actin (Chalovich et al.,  1983;  Pemrick and Weber,  1976). 
These modified myosins were copolymerized with either 
phosphorylated smooth or unmodified skeletal muscle myosin 
to assess how cross-bridges with different binding strengths 
to actin can modulate the velocity of actin movement. 
Warshaw et al.  Cross-bridge Interactions  Modulate  Actin  Velocity  457 Figure 4.  Electron micrographs of negatively stained myosin filaments in the presence of antibody LMM.I.  (A) Copolymers of un- 
phosphorylated  smooth and skeletal muscle myosin  (equal proportions). (B) Homopolymers  of  unphosphorylated  smooth and skeletal mus- 
cle myosin (equal mixtures). (C) Unphosphorylated smooth muscle myosin homopolymers. (D) Skeletal muscle myosin homopolymers. 
Arrowheads identify 15-nm periodic antibody binding. Bar, 0.1 /~m. 
The presence of as little as 1.0 % of the strong binding ana- 
logue (NEM-myosin) in a copolymer was sufficient to com- 
pletely inhibit movement of actin by either phosphorylated 
smooth or unmodified skeletal muscle myosin.  Once the 
proportion of NEM-myosin within the copolymer was re- 
duced to <1.0%, actin moved with a velocity equal to that 
observed for homopolymers of phosphorylated smooth or 
unmodified skeletal muscle myosin. 
The effect of the weak binding myosin analogue (pPDM- 
myosin) on actin velocity was more gradual (Fig. 6).  10% 
pPDM-myosin  copolymerized  with  unmodified  skeletal 
muscle myosin reduced actin filament velocity  below that ob- 
served for skeletal muscle myosin homopolymers. The ve- 
locity was  further  reduced  as  the  proportion  of pPDM- 
myosin within the copolymer increased until actin filament 
motion was completely inhibited in the presence of 50% 
pPDM-myosin. In contrast, a greater proportion of pPDM- 
myosin (i.e., 75 %) was needed to affect the movement of ac- 
tin by phosphorylated smooth muscle myosin. The pattern 
of modulation of actin filament velocity by the weak binding 
analogue is  strikingly similar to that observed  when un- 
phosphorylated smooth muscle myosin was copolymerized 
with phosphorylated smooth or skeletal muscle myosin. 
Discussion 
Smooth muscle's high economy of force maintenance during 
prolonged isometric contractions is in part due to a reduction 
in the  cross-bridge  cycling rate  with time of contraction 
(Siegman et al., 1980; Dillon et al., 1981). One mechanism 
that could account for a lower cycling rate during force main- 
tenance  is  a  mechanical  interaction between  two  cross- 
bridge populations within the same myosin filament, i.e., 
rapid cycling phosphorylated and slowly or noncycling de- 
phosphorylated cross-bridges (Dillon et al., 1981). This hy- 
pothesis was tested here by observing the rate of movement 
of fluorescently labeled actin filaments on phosphorylated/ 
unphosphorylated smooth muscle myosin copolymers. The 
results suggest that the apparent modulatory role of light 
chain phosphorylation is a consequence of mechanical inter- 
actions between cross-bridges having different cycling rates 
and strengths of binding to actin. 
Key Features of the Motility Assay 
Although the in vitro movement of actin by skeletal muscle 
myosin has  been  well  characterized  (Kron and  Spudich, 
1986; Harada et al., 1987), a detailed study of actin filament 
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Figure 5.  (A) Actin filament velocity versus percentage of un- 
phosphorylated  smooth (upper axis) or skeletal muscle myosin 
(lower axis) in the copolymer. Copolymers were stabilized by anti- 
body against the depolymerizing effect of MgATP. Since no motion 
was detected at proportions of unphosphorylated smooth muscle 
myosin that exceeded 50 %, the minimum resolvable velocity was 
assigned. Velocities are normalized to the maximum for skeletal 
muscle myosin (2.17 #m/s). (B) Actin filament velocity versus per- 
centage of phosphorylated smooth (upper axis) or skeletal muscle 
myosin (lower  axis) in the copolymer. Different symbols represent 
two different experiments. Velocities are normalized to the maxi- 
mum for skeletal muscle myosin (o, 3.87 #m/s;  A, 2.38 #m/s). 
Curves were fit by eye. 
motion on smooth muscle myosin has not been reported. 
Some of the key features are described below. The velocity 
at which actin moves over phosphorylated smooth muscle 
myosin is independent of actin filament length (Fig. 2 A), as 
observed previously for skeletal muscle myosin (Kron and 
Spudich, 1986; Harada et al., 1987). These data suggest that 
although increased actin filament lengths provide more op- 
portunity for cross-bridge interactions, actin velocity is inde- 
pendent of cross-bridge number. This may be analogous to 
the observation that in intact skeletal muscle, the maximum 
shortening velocity is independent of the extent of actin and 
myosin filament overlap within the sarcomere (i.e., number 
of cycling cross-bridges) (Edman,  1979). 
Phosphorylated smooth muscle myosin, like skeletal myo- 
sin, propels actin filaments at a rate dependent on MgATP 
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Figure 6. Actin filament velocity versus the percentage of pPDM- 
modified myosin copolymerized with either unmodified phosphor- 
ylated smooth or skeletal muscle myosin. Velocities are normalized 
to their respective maximums (smooth, 0.23 #m/s; skeletal, 2.46 
#m/s).  Curves fit by eye. 
concentration (Fig. 2 B) (Kron and Spudich, 1986; Harada 
et al.,  1987). The MgATP concentration (29 #M) for half- 
maximal velocity in the motility assay is, however, 10 times 
greater than the K~ for the actomyosin ATPase of isolated 
proteins in solution (Moos,  1973).  A possible explanation 
for this difference is that while a small amount of rigor cross- 
bridges can impede the movement of actin by cycling cross- 
bridges (Kron and Spudich,  1986; Harada et al.,  1987), a 
small  population of rigor  cross-bridges  does  not  greatly 
affect the overall turnover of MgATP in solution. If this in- 
terpretation is correct, then the motility assay provides addi- 
tional information about mechanical interactions between 
cross-bridges which can not be obtained from solution bio- 
chemistry. 
Modulation of the Velocity of  Actin Movement 
If changes in the state of myosin light chain phosphorylation 
act only as a switch to turn rapid cross-bridge cycling on and 
off, then the velocity of actin movement should be indepen- 
dent of  the percentage of phosphorylated cross-bridges within 
the myosin filament. The observation that actin velocity de- 
pended on the ratio of phosphorylated to unphosphorylated 
myosin suggests that these two cross-bridge populations can 
also interact mechanically. The experiments described here 
also established that small amounts of smooth muscle myo- 
sin can inhibit movement of actin by the much faster cycling 
skeletal muscle myosin. 
A  somewhat similar, but less steep relationship between 
actin velocity and the percentage of phosphorylated myosin 
in  smooth  muscle  myosin  copolymers  was  obtained  by 
Sellers et al. (1985) using an earlier version of the motility 
assay. In this assay, myosin-coated polystyrene beads moved 
on actin cables in the dissected wall of the algae, Nitella. The 
smooth muscle myosin copolymers, in this  earlier study, 
were not stabilized to disassembly by nucleotide, thus the 
initial proportion of phosphorylated and unphosphorylated 
cross-bridge heads within a myosin filament probably were 
not maintained throughout the assay. Here, a monoclonal an- 
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each bead in the Nitella assay was coated with a thick matrix 
of aggregated myosin filaments (see Fig. 2 in Sellers et al., 
1985). Here, an even distribution of filaments was laid onto 
nitrocellulose (Fig. 1 B). Therefore the observed bead veloc- 
ity did not result from as simplified a contractile protein sys- 
tem as in the present study where •50  cross-bridge heads 
produce motion of a single actin filament. 
Based on biochemical evidence,  it is surprising that un- 
phosphorylated  smooth  muscle  myosin  cross-bridges  can 
cause such a large resistance to actin movement.  The rate- 
limiting  step for  MgATP  hydrolysis by unphosphorylated 
smooth muscle myosin is the release of inorganic phosphate 
from the complex of actomyosin and the products of ATP hy- 
drolysis (Sellers,  1985). This step in the cross-bridge cycle 
is believed to be associated with the transition from a weakly 
to a strongly bound cross-bridge state.  Therefore, unphos- 
phorylated smooth muscle myosin cross-bridges should exist 
predominantly  in a  weakly bound state,  rapidly  attaching 
and detaching from actin (Eisenberg et ai.,  1980). Experi- 
mentally, unphosphorylated filaments bind strongly enough 
to actin in the presence of MgATP to prevent the actin from 
freely floating into solution. One might have assumed, how- 
ever, that such a rapid attachment and detachment from actin 
(>l,000/s)  would offer little resistance to actin movement. 
This assumption is based on mechanical studies in skinned 
skeletal muscle fibers which show that in relaxed muscle, 
cross-bridges at physiological ionic strength exist predomi- 
nantly in a weakly bound state that offers little resistance to 
stretch.  When the ionic strength of the bathing  solution is 
lowered, the cross-bridges bind more tightly and only then 
can  the  weakly bound  cross-bridges  be detected  through 
measurements of fiber stiffness (Brenner et al.,  1982). Be- 
cause the in vitro motility assay is performed at low ionic 
strength,  the apparent load that unphosphorylated  smooth 
mtiscle myosin cross-bridges place on faster cycling phos- 
phorylated cross-bridges may be higher than at physiological 
ionic strength. Smooth muscle myosin shows tess of an ionic 
strength dependence of binding to actin than skeletal muscle 
myosin  (Greene  et  al.,  1983),  however,  such  that  un- 
phosphorylated  smooth muscle myosin cross-bridges  may 
exert  a  drag  to  movement  even  at  physiological  ionic 
strength. 
Given this  interpretation,  how can  the  relaxed  state  in 
smooth  muscle  be  achieved?  One  possibility  is  that  the 
smooth  muscle  cell  contains  a  protein  that  prevents  un- 
phosphorylated myosin from attaching to actin in the relaxed 
state; Actin binding proteins such as caldesmon may serve 
this regulatory role as suggested by their ability to inhibit 
actomyosin ATPase activity in vitro (Clark et ai., 1986). Al- 
ternatively, Siegman et al. (1976) have reported calcium-de- 
pendent resistance to stretch in relaxed taenia coli, suggest- 
ing that significant numbers of presumably unphosphorylated 
cross-bridges may be attached in relaxed muscle, in agree- 
ment with these motility data. 
In an attempt to show by another approach that biochemi- 
tally defined weakly bound cross-bridges are capable of in- 
hibiting  fast cycling cross-bridges,  skeletal muscle myosin 
was  modified  with  pPDM  to  produce  an  analogue  of a 
weakly bound  noncycling  cross-bridge  (Chalovich  et al., 
1983). Copolymers containing either phosphorylated smooth 
or skeletal muscle myosin and the weakly bound cross-bridge 
analogue  showed reduced  velocities  as  the  proportion  of 
pPDM-myosin within the myosin filament increased,  con- 
firming that weakly bound noncycling cross-bridges have the 
ability to impede faster cycling cross-bridges. Both the quali- 
tative and quantitative similarities in the modulation of actin 
filament velocity caused by unphosphorylated smooth mus- 
cle myosin and pPDM-myosin suggest that these two cross- 
bridge species are mechanically indistinguishable.  In vitro, 
therefore,  unphosphorylated  smooth muscle myosin cross- 
bridges most likely exist in a state that is weakly bound to 
actin (Sellers,  1985). 
How can weakly bound cross-bridges exert a load to faster 
cycling cross-bridges? One possible explanation is that the 
rates  of attachment  and  detachment  are  strain  dependent 
(Somlyo et al., 1988). Any weakly bound cross-bridges that 
are attached to aetin could be strained as the filament moves. 
This  could result in altered  kinetics  such that the weakly 
bound cross-bridges become more tightly bound and then re- 
tard the faster cyeling cross-bridges. 
The most profound effect on actin filament velocity was 
observed when the strong binding myosin analogue (NEM- 
myosin)  was present  in  a  copolymer.  Only  1.0%  NEM- 
myosin  was  needed  to  completely  inhibit  actin  motion. 
Given that the dissociation constant for this strongly bound 
cross-bridge analogue is very low,  it is not surprising that 
these cross-bridges can anchor actin to the myosin copoly- 
mer. A similar reduction in the rate of actin movement oc- 
curs when nonsamrating concentrations of MgATP are used 
in the motility assay, and small amounts of rigor bridges are 
present. 
Model  for Cross-bridge Mechanical Interactions 
To explain the observed relationships between actin velocity 
and myosin filament composition, the following cross-bridge 
interaction model was developed (see Appendix for details). 
The model's basic premise is that if a filament contains myo- 
sins that have different cycling rates and affinities for actin, 
then the mechanical interaction between these cross-bridges 
determines the overall cycling rate of the entire cross-bridge 
population. 
Based on our present understanding  of the cross-bridge 
mechanism in muscle, the model's most crucial assumptions 
are the following.  (a) Cross-bridges act independently.  (b) 
The ability of a cycling cross-bridge to generate force and 
move an actin filament is described by a hyperbolic force 
versus velocity relationship  similar to that observed in the 
whole muscle  (see Fig.  7  C).  (c)  As  fast cycling cross- 
bridges propel an actin filament, the compression (i.e., nega- 
tive  strain)  of attached,  slower cycling  or  weakly bound 
cross-bridges  results  in  an  internal  load that  opposes the 
faster  cycling  cross-bridges;  (d)  The  internal  load  (i.e., 
negative  force)  and  the  velocity  at  which  the  slower  or 
weakly bound cross-bridges are being compressed are de- 
scribed by a force/compression velocity relationship. For cy- 
cling cross-bridges, this relationship may be continuous with 
the  force/velocity relationship  defined  for  positive  forces 
(evidence for this is based on the report by Edman (1979) in 
whole skeletal muscle); (e) Viscous drag on the moving actin 
filament is negligible (Sheetz and" Spudich, 1983). 
To implemerit the model, force/velocity relationships must 
be specified for the various myosins:  Since these relation- 
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Figure 7. Predicted relationships for actin filament velocity versus 
myosin copolymer composition using a model for crossbridge me- 
chanical interactions (see Appendix). (A) Observed data (open and 
solid symbols) from individual copolymer mixtures were optimally 
fitted (solid and  dashed curves) using hypothetical crossbridge 
force/velocity relationships having a/Po values in parentheses next 
to each curve [(fast a/Po)/(slow a/Po)]. (Observed data taken from 
Fig. 3 A at 25 mM KCI, 5A and 5B). Standard deviation bars were 
omitted for the smooth/skeletal copolymer data for clarity. (B) 
Copolymer data were simultaneously fitted using a single set of 
force:velocity relationships. (a/Po; phosphorylated smooth, 0.60; 
unphosphorylated smooth, 0.15; skeletal, 0.t0.) With this more 
stringent test of the model, the curvature of the predicted relation- 
ships follow the data, but the actual fits are somewhat poorer than 
in A, particularly for the smooth/skeletal copolymers. (C) Hypo- 
thetical cross-bridge force/velocity relationships for fast and slow 
myosins. The predicted actin velocities for myosin  copolymers hav- 
ing 25, 50, or 75 % fast myosin are graphically displayed. For exam- 
ships were not available for the myosins studied, force/veloc- 
ity relationships were assumed. The curves were, however, 
constrained by curvatures (i.e., hyperbolic constant of a/Po) 
reported in the literature for smooth and skeletal muscles 
(Hellstrand and Paul,  1982;  Woledge et al.,  1985)  and by 
measured maximum actin filament velocities in the motility 
assay. With these constraints, the observed relationship be- 
tween actin filament velocity and myosin filament composi- 
tion (Fig. 7 A) could be adequately fit to within one standard 
deviation of the actual data for any given copolymer. How- 
ever, when all the various smooth and skeletal muscle myo- 
sin copolymer data were simultaneously fitted with a single 
set of force/velocity relationships, the general shapes of the 
predicted relationships were appropriate but the fits were not 
as good (see Fig. 7 B). The poorer fit for this stringent test 
might indicate that other phenomena, such as cooperativity 
between neighboring cross-bridges, may be a factor in deter- 
mining actin filament velocity. Another possibility is that the 
force/velocity relationship from whole muscle is too macro- 
scopic  a  relationship  to  adequately  describe  mechanical 
events in the motility assay. A critical test of  the model would 
be to measure actin filament velocities using myosins from 
muscles that have well characterized force/velocity relation- 
ships.  Nevertheless, this simple model, in which slowly cy- 
cling or weakly bound cross-bridges mechanically oppose 
the propulsive forces of faster cycling cross-bridges, does 
serve an important first step in explaining the myosin copoly- 
mer data. 
If the model's assumptions are correct, then unphosphor- 
ylated smooth muscle myosin cross-bridges can sustain nega- 
tive forces.  This would support the earlier contention of 
Murphy and co-workers that dephosphorylated cross-bridges 
present an internal load to the cycling phosphorylated popu- 
lation (Dillon et al., 1981). However, Hal and Murphy (1988) 
have more recently suggested that the overall cycling rate for 
a cross-bridge population containing both dephosphorylated 
and phosphorylated bridges is merely a weighted average of 
the two populations rather than a mechanical interaction be- 
tween heads. This modification  to the latchbridge hypothesis 
would accommodate the findings of Butler et al. (1986) who 
argue against an internal load based on energetic considera- 
tions. These motility data, however, strongly suggest that in 
vitro, cross-bridges do mechanically interact. 
Conclusions 
The ability of unphosphorylated smooth muscle myosin to 
impede skeletal muscle myosin to a greater extent than it 
does phosphorylated smooth muscle myosin may indicate 
that smooth muscle cross-bridges spend a greater fraction of 
their cycle time in the strongly bound, high-force producing 
state (i.e., greater duty cycle) than skeletal myosin cross- 
bridges.  This  conclusion  agrees  with  physiological data 
(Warshaw and Fay, 1983; Warshaw,  1987; Yamakawa et al., 
1990),  which suggest an increased duty cycle for smooth 
pie, when the fraction  of fast myosin  (k) is 0.75, the predicted  velocity 
of 0.41 V,~ is achieved when Ps =  -3Pf (see Eq. 5 in Appendix). 
At this value, the propelling force of the faster cycling  crossbridges 
(Pf, dotted line) is opposed by the compressive force of the slower 
cycling crossbridges (P,, dashed line) so that the net force equals 
Zero. 
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smooth inuscle to generate comparable forces to skeletal 
muscle with far less myosin (Cohen and Murphy, 1979). 
The in vitro motility assay has proven to be a valuable tool 
for  studying  interactions  between  myosin cross-bridges 
within a  filament. The model proposed here may also be 
generally applied to  the  mechanics of whole muscles in 
which multiple myosin isoforms are expressed.  In the de- 
veloping rat soleus muscl0, for example, both fast and slow 
myosin isoforms are simultaneously expressed. Correlation, 
of maximum shortening velocity with myosin isoform com- 
position suggests that the slower isoforms profoundly affect 
the muscle's: maximum shortening velocity (Reiser et al., 
1988) as is the case with actin velocity in the motility assay. 
Further studies will be needed, however, to address the ques- 
tion of why weakly bound cross-bridges (i.e., unphosphor- 
ylated smooth muscle myosin or pPDM-treated myosin) offer 
substantial resistance to actin filament motion. Direct mea- 
surement of  the force produced by unphosphorylated smooth 
muscle cross-bridges interacting with a single actin filament 
may resolve this question (Kishino and Yanagida,  1988). 
Appendix 
Model for Cross-bridge Mechanical Interactions  in 
Myosin Copolymers 
A model has been developed to predict the velocity at which 
actin filaments move over myosin copolymers. The model's 
basic assumptions are described in the Discussion. Addi- 
tional assumptions and details of the calculations are pre- 
sented here. 
Model Assumptions 
(a) In a myosin copolymer consisting of fast (f) and slow (s) 
cycling cross-bridges,  the cross-bridge force/velocity rela- 
tionships  (P/V)  for the individual myosin species are  as- 
sumed to be rectangular hyperbolas (Hill, 1938) and to exist 
for both positive and negative forces: 
Vf  =  bf[[(eof  +  af)/(P,  +  a,)]  -  1]  (1) 
Vs  =  bs[l(Pos  +  as)/(P~  +  as)]  -  1],  (2) 
where Po is the maximum positive cross-bridge force and a 
and b are constants that define the shape of the force/velocity 
relationship. For all equations and assumptions described in 
this Appendix, the term "weakly bound" can be substituted 
for "slow cycling." However,  weakly bound bridges are as- 
sumed not to cycle and thus do not generate positive force. 
Therefore only a  force/compression velocity relationship 
need be described (i.e., P  <  0) for weakly bound bridges. 
Additional assumptions for the cross-bridge force/velocity 
relationships are that fast and slow cycling cross-bridges: (a) 
generate comparable maximum forces, Pof  =  Pos  (this is 
not a necessary assumption); (b) have maximum velocities 
(Vm~x) at zero force that are measured in the motility assay 
and normalized to the actin filament velocity using skeletal 
muscle myosin (Vm~x of Skeletal  =  1.0; Smooth Phos.  = 
0.08; Smooth Unphos. = 0.014); (c) have force/velocity  rela- 
tionships with a/Po values (i.e., Curv-dtures) within the range 
of !!terature values (0.1-1.25).  The exact value was selected 
by a least squares optimization routine to give the best fit of 
the model to the observed actin filament velocity versus myo- 
sin filament composition data. 
(b) If actin filaments are rigid, then any cross-bridge at- 
tached to an actin filament must move at the same velocity 
as the actin filament (I~), regardless of the cross-bridge's in- 
herent cycling rate.  Therefore any fast and  slow  cycling 
cross-bridges that are attached to the same moving actin fila- 
ment must have equal velocities: 
va  =  v,  =  Ve.  (3) 
(c) Cross-bridges within a myosin filament are assumed to 
act  mechanically in  parallel.  Therefore the  mean  cross- 
bridge force (i0) equals the sum of the fast and slow cycling 
cross-bridge force contributions: 
P  =  kPf  +  (1  -  k)P,  (4) 
where k and (1 -  k) are the fractions of fast and slow cycling 
cross-bridges within the myosin copolymer, respectively. 
(d) Assuming that actin filaments do not experience any 
significant viscous drag (see calculations for relatively large 
myosin coated beads in Sheetz and Spudich,  1983),  then 
both the external force on the actin filament and/~ equal zero 
as the actin filament freely moves over myosin. Therefore 
from Eq. 4: 
kPf =  (k  -  1)Ps.  (5) 
Thus for actin filament movement, the fast cycling cross- 
bridge population must generate a force that is equal and op- 
posite to the internal load created by the compression or 
negative strain of the slower cross-bridge population. 
Model Calculations  and Predictions 
To predict the resultant actin filament velocity for a given 
myosin copolymer, one must first determine the internal load 
(Ps) of the slowly cycling cross-bridge population. For any 
fraction of slow cycling cross-bridges, Ps can be obtained 
algebraically by solving Eq.  5  for Pf and substituting Pf 
into Eq. 1. After this substitution, Eqs. 1 and 2 are set equal 
to each other as in Eq.  3.  These manipulations result in a 
quadratic equation that can be solved for Ps: 
AI ~  +  A2P~ +  A3  =  O, 
where: 
Al  =  (b~  -  be) (k -  1)/k, 
A2  =  (bs  -  bf)  (af  +  as(k  -  1)/k) +  bf(Pof  "t-  af)  - 
bs(k  -  1)/k) (Po~ +  a~),  and 
A3  =  (bs  -  bf)afa,  +  bf(Pofa~  +  asaf)  -  b~f(Po~  +  as), 
with A1, A2, and A3 in terms of the force/velocity constants 
(a and b,  where b  =  Vm,~[a/Po]),  maximum cross-bridge 
force, and fractions of fast and slow cycling cross-bridges. 
Once the internal load (Ps) is determined for any mixture 
of fast and slow cross-bridges, the actin filament velocity 
(V,) associated with this mixture is equal to Vs and calcu- 
lated from Eq. 2. 
The  model  predictions  can  also  be  obtained  through 
graphical analysis (see Fig. 7 C). The shapes of  the force/ve- 
locity relationships are critical to the predictions and may re- 
quire revision once the techniques to measure the cross- 
bridge force/velocity relationship in the motility assay have 
been developed. For a sample prediction, the actin filament 
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and fast myosin (i.e.,  k  =  0.5) can be determined from the 
condition where the positive propelling force of the faster cy- 
cling bridges (Pt) equals the opposing negative force of the 
slower bridges (Ps). For other proportions, one scales along 
the  force  axis  so that the Pf equals  [(k  -  1)/k]P,.  As the 
fraction of fast cycling cross-bridges  is reduced,  fewer fast 
cycling bridges share the slow cross-bridges' internal load. 
This results in an increased force per fast cycling cross-bridge 
and decreased cycling rate as predicted by the force/velocity 
relationship. 
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